The DOI matches its Crossref record; 435 of the 435 references it cites were found in a registry or an index.
Modulating ROS to overcome multidrug resistance in cancer
Abstract
The successful treatment of cancer has significantly improved as a result of targeted therapy and immunotherapy. However, during chemotherapy, cancer cells evolve and can acquire "multidrug resistance" (MDR), which significantly limits the efficacy of cancer treatment and impacts patient survival and quality of life. Among the approaches to reverse MDR, modulating reactive oxidative species (ROS) may represent a strategy to kill MDR cancer cells that are mechanistically diverse. ROS in cancer cells play a central role in regulating and inducing apoptosis, thereby modulating cancer cells proliferation, survival and drug resistance. The levels of ROS and the activity of scavenging/anti-oxidant enzymes in drug resistant cancer cells are typically increased compared to non-MDR cancer and normal cells. Consequently, MDR cancer cells may be more susceptible to alterations in ROS levels. Numerous studies suggest that compounds modulating cellular ROS levels can enhance MDR cancer cell death and sensitize MDR cancer cells to certain chemotherapeutic drugs. In the current review, we discuss the critical and targetable redox-regulating enzymes, including mitochondrial electron transport chain (ETC) complexes, NADPH oxidases (NOXs), enzymes related to glutathione metabolism, glutamate/cystine antiporter xCT, thioredoxin reductases (TrxRs), nuclear factor erythroid 2-related factor 2 (Nrf2), and their roles in regulating cellular ROS levels, drug resistance as well as their clinical significance. We also discuss and summarize the findings in the past decade regarding the efficacy of ROS modulators for the treatment of MDR cancer alone or as sensitizing compounds. Compounds that are efficacious in modulating ROS generation represent a prominent class of drug candidates that warrants evaluation in clinical trials for patients harboring MDR cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 201–400 of 435
NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells
Rocha, C. R. R., Kajitani, G. S., Quinet, A., Fortunato, R. S., & Menck, C. F. M. (2016) · Oncotarget · doi:10.18632/oncotarget.10129 · Cited by 135
Peng, X., Zhang, M., Conserva, F., Hosny, G., Selivanova, G., Bykov, V. J. N., Arnér, E. S. J., & Wiman, K. G. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.137 · Cited by 134
Lee, S., Lim, M., Kim, M., Yu, C., Yun, Y., Ahn, J., & Song, J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.038 · Cited by 133
DNA Mismatch Repair and Oxidative DNA Damage: Implications for Cancer Biology and Treatment
Bridge, G., Rashid, S., & Martin, S. A. (2014) · Cancers · doi:10.3390/cancers6031597 · Cited by 132
High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy
Eriksson, S. E., Prast‐Nielsen, S., Flaberg, E., Székely, L., & Arnér, E. S. J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.09.016 · Cited by 132
Shim, G.-S., Manandhar, S., Shin, D., Kim, T., & Kwak, M. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.09.006 · Cited by 131
Wang, J., Luo, B., Li, X., Lu, W., Yang, J., Hu, Y., Huang, P., & Wen, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.272 · Cited by 127
Self-citationVasodilatory action mechanisms of apigenin isolated from Apium graveolens in rat thoracic aorta
Ko, F., Huang, T., & Teng, C. (1991) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(91)90013-7 · Cited by 126
Pulliam, N., Fang, F., Özeş, A., Tang, J., Adewuyi, A., Keer, H. N., Lyons, J. F., Baylin, S. B., Matei, D. E., Nakshatri, H., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0204 · Cited by 126
Burch, P. M., & Heintz, N. H. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.741 · Cited by 124
Awasthi, S., Singhal, S. S., Sharma, R., Zimniak, P., & Awasthi, Y. C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11260 · Cited by 120
Selenium-Containing Chrysin and Quercetin Derivatives: Attractive Scaffolds for Cancer Therapy
Martins, I. L., Charneira, C., Gandin, V., da Silva, J. F., Justino, G. C., Telo, J. P., Vieira, A. J. S. C., Marzano, C., & Antunes, A. M. M. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00230 · Cited by 120
Speijer, D. (2010) · BioEssays · doi:10.1002/bies.201000097 · Cited by 117
Raedler, L. A. (2015) · PubMed · Cited by 116
Porporato, P. E., Payen, V. L., Baselet, B., & Sonveaux, P. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2100-2 · Cited by 116
Thiamine and selected thiamine antivitamins — biological activity and methods of synthesis
Tylicki, A., Łotowski, Z., Siemieniuk, M., & Ratkiewicz, A. (2017) · Bioscience Reports · doi:10.1042/bsr20171148 · Cited by 116
Chian, S., Li, Y., Wang, X. J., & Tang, X. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.6.2911 · Cited by 114
Su, Z., Chen, M., Xiao, Y., Sun, M., Zong, L., Asghar, S., Dong, M., Li, H., Ping, Q., & Zhang, C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.020 · Cited by 113
Zhong, Y., Zhang, F., Sun, Z., Zhou, W., Li, Z., You, Q., Guo, Q., & Hu, R. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21921 · Cited by 112
Zeng, L., Chen, Y., Liu, J., Huang, H., Guan, R., Ji, L., & Chao, H. (2016) · Scientific Reports · doi:10.1038/srep19449 · Cited by 112
Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy
Edelman, R., Assaraf, Y. G., Levitzky, I., Shahar, T., & Livney, Y. D. (2017) · Oncotarget · doi:10.18632/oncotarget.15363 · Cited by 111
Self-citationGene expression signature of primary imatinib-resistant chronic myeloid leukemia patients
Frank, O., Brors, B., Fabarius, A. C., Li, L., Haak, M., Merk, S., Schwindel, U., Zheng, C., Müller, M. C., Gretz, N., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404270 · Cited by 110
Okon, I. S., Coughlan, K. A., Zhang, M., Wang, Q., & Zou, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.631580 · Cited by 110
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines
Michaelis, M., Kleinschmidt, M. C., Barth, S., Rothweiler, F., Geiler, J., Breitling, R., Mayer, B., Deubzer, H. E., Witt, O., Kreuter, J., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.013 · Cited by 110
Hou, G., Liu, P., Zhang, S., Yang, M., Liao, J., Yang, J., Hu, Y., Jiang, W.-Q., Wen, S., & Huang, P. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0159-4 · Cited by 109
Sulphasalazine: A Review of 40 Years?? Experience
Watkinson, G. (1986) · Drugs · doi:10.2165/00003495-198600321-00003 · Cited by 107
Juhasz, A. N., Markel, S., Gaur, S., Liu, H., Lu, J., Jiang, G., Wu, X., Antony, S., Wu, Y., Melillo, G., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.768283 · Cited by 107
Whitaker, H., Patel, D., Howat, W., Warren, A., Kay, J., Sangan, T., Marioni, J., Mitchell, J., Aldridge, S., Luxton, H. J., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.396 · Cited by 105
Hu, Y., Lu, W., Chen, G., Zhang, H., Jia, Y., Wei, Y., Yang, H., Zhang, W., Fiskus, W. C., Bhalla, K. N., et al. (2010) · Blood · doi:10.1182/blood-2009-11-256354 · Cited by 104
Ball, W. B., Kar, S., Mukherjee, M., Chande, A. G., Mukhopadhyaya, R., & Das, P. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004237 · Cited by 101
Shi, Z., He, J., Yao, T., Chang, W., & Zhao, M. (2004) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2004.11.015 · Cited by 101
SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties
Polewski, M. D., Reveron‐Thornton, R. F., Cherryholmes, G. A., Marinov, G. K., & Aboody, K. S. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0123 · Cited by 101
Zhang, H., Trachootham, D., Lu, W., Carew, J. S., Giles, F. J., Keating, M. J., Arlinghaus, R. B., & Huang, P. (2008) · Leukemia · doi:10.1038/leu.2008.74 · Cited by 100
Tsuboi, K., Bachovchin, D. A., Speers, A. E., Spicer, T., Fernández-Vega, V., Hodder, P., Rosen, H., & Cravatt, B. F. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2066972 · Cited by 100
Role of glutathione in cancer pathophysiology and therapeutic interventions.
Singh, S., Khan, A. R., & Gupta, A. K. (2012) · PubMed · Cited by 100
Wang, S., Chen, M.-S., Chou, Y., Ueng, Y., Yin, P., Yeh, T.-S., & Lee, H. (2016) · Oncotarget · doi:10.18632/oncotarget.12356 · Cited by 100
Wang, J., Wang, H., Sun, K., Wang, X., Pan, H., Zhu, J., Ji, X., & Li, X. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s160020 · Cited by 100
Self-citationNADPH oxidases: new actors in thyroid cancer?
Hassani, R. A. E., Schlumberger, M. J., & Dupuy, C. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.64 · Cited by 99
HOSOKI, A., YONEKURA, S.-I., ZHAO, Q.-L., WEI, Z.-L., TAKASAKI, I., TABUCHI, Y., WANG, L.-L., HASUIKE, S., NOMURA, T., TACHIBANA, A., et al. (2012) · Journal of Radiation Research · doi:10.1269/jrr.11034 · Cited by 97
Piaggi, S., Raggi, C., Corti, A., Pitzalis, E., Mascherpa, M. C., Saviozzi, M., Alfonso Pompella, C., & Casini, A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq031 · Cited by 96
Villablanca, J. G., Volchenboum, S. L., Cho, H., Kang, M. H., Cohn, S. L., Anderson, C. P., Marachelian, A., Groshen, S. G., Tsao-Wei, D. D., Matthay, K. K., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.25994 · Cited by 96
NADPH Oxidases NOXs and DUOXs as Putative Targets for Cancer Therapy
Weyemi, U., Redon, C. E., Parekh, P. R., Dupuy, C., & Bonner, W. M. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611313030013 · Cited by 95
Federici, L., Sterzo, C. L., Pezzola, S., Matteo, A. D., Scaloni, F., Federici, G., & Caccuri, A. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1314 · Cited by 95
Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo
Parekh, A., Das, S., Parida, S., Das, C. K., Dutta, D., Mallick, S. K., Wu, P.-H., Kumar, B. N. P., Bharti, R., Dey, G., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0272-6 · Cited by 95
Shen, Y., Yang, J., Zhao, J., Xiao, C., Xu, C., & Xiang, Y. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.04.010 · Cited by 94
Liu, D. S. H., Read, M. D., Cullinane, C. M., Azar, W. J., Fennell, C. M., Montgomery, K. G., Haupt, S., Haupt, Y., Wiman, K. G., Duong, C. P., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-309770 · Cited by 94
Regulation of xCT expression and system $$ x_{\text{c}}^{ - } $$ function in neuronal cells
Lewerenz, J., Maher, P. A., & Methner, A. (2011) · Amino Acids · doi:10.1007/s00726-011-0862-x · Cited by 93
Banning, A., Kipp, A. P., Schmitmeier, S., Löwinger, M., Florian, S., Krehl, S., Thalmann, S., Thierbach, R., Steinberg, P., & Brigelius‐Flohé, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1321 · Cited by 92
Improving Adherence to Oral Cancer Therapy in Clinical Practice
McCue, D. A., Lohr, L., & Pick, A. M. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1399 · Cited by 92
Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
Likus, W., Siemianowicz, K., Bieńk, K., Pakula, M. M., Pathak, H., Dutta, C., Wang, Q., Shojaei, S., Assaraf, Y. G., Ghavami, S., et al. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.02.001 · Cited by 92
Self-citationAnticancer Drugs Targeting the Mitochondrial Electron Transport Chain
Rohlena, J., Dong, L.-F., Ralph, S. J., & Neuzil, J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3990 · Cited by 91
Li, X., Fan, X., Jiang, Z., Loo, W. T., Yao, X., Leung, E. L., Chow, L. W., & Liu, L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.011 · Cited by 91
GlutathioneS-Transferase π1 Promotes Tumorigenicity in HCT116 Human Colon Cancer Cells
Dang, D. T., Chen, F., Kohli, M., Rago, C., Cummins, J. M., & Dang, L. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1930 · Cited by 90
Yasuda, S., Yogosawa, S., Izutani, Y., Nakamura, Y., Watanabe, H., & Sakai, T. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900165 · Cited by 90
Chen, G., Chen, Z., Hu, Y., & Huang, P. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4170 · Cited by 89
Self-citationBaldo, B. A., & Pham, N. H. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9447-3 · Cited by 89
Glutathione Peroxidase-1 Protects from CD95-induced Apoptosis
Gouazé‐Andersson, V., Andrieu‐Abadie, N., Cuvillier, O., Malagarie‐Cazenave, S., Frisach, M., Mirault, M.-É., & Levade, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203067200 · Cited by 88
The diverse roles of glutathione-associated cell resistance against hypericin photodynamic therapy
Theodossiou, T. A., Olsen, C. E., Jonsson, M., Kubin, A., Hothersall, J. S., & Berg, K. (2017) · Redox Biology · doi:10.1016/j.redox.2017.02.018 · Cited by 88
Possible Enzymic Mechanism for the Development of Resistance against Fluorouracil in Ascites Tumours
Reichard, P. A., Sköld, O., & Klein, G. (1959) · Nature · doi:10.1038/183939a0 · Cited by 87
Leung, E. L., Fan, X., Wong, M. P., Jiang, Z., Liu, Z., Yao, X., Lu, L., Zhou, Y., Yau, L.-F., Tin, V. P., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6420 · Cited by 87
Ju, H., Lu, Y., Chen, D.-L., Tian, T., Mo, H., Wei, X., Liao, J.-W., Wang, F., Zeng, Z.-L., Pelicano, H., et al. (2016) · Theranostics · doi:10.7150/thno.14848 · Cited by 87
Targeting Cancer Cell Mitochondria as a Therapeutic Approach: Recent Updates
Cui, Q., Wen, S., & Huang, P. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0011 · Cited by 87
Self-citationA tribute to Sidney Farber – the father of modern chemotherapy
Miller, D. R. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06119.x · Cited by 86
Saponins of the Ivy Plant,Hedera helix, and their Leishmanicidic Activity
Savornin, B., Élias, R., Dı́az-Lanza, A. M., Balansard, G., Gasquet, M., & Delmas, F. (1991) · Planta Medica · doi:10.1055/s-2006-960086 · Cited by 85
ROS signalling, NADPH oxidases and cancer
Landry, W. D., & Cotter, T. G. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140060 · Cited by 85
Role of mitochondrial uncoupling protein 2 in cancer cell resistance to gemcitabine
Dalla Pozza, E., Fiorini, C., Dando, I., Menegazzi, M., Sgarbossa, A., Costanzo, C., Palmieri, M., & Donadelli, M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.06.007 · Cited by 84
Chen, X., Shi, X., Zhao, C., Li, X., Lan, X., Liu, S., Huang, H., Liu, N., Liao, S., Zang, D., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2361 · Cited by 82
Scarbrough, P. M., Mapuskar, K. A., Mattson, D., Gius, D. R., Watson, W. H., & Spitz, D. R. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.493 · Cited by 82
Fath, M. A., Diers, A. R., Aykin‐Burns, N., Simons, A. L., Hua, L., & Spitz, D. R. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.13.8631 · Cited by 82
NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells
Zeng, C., Wu, Q., Wang, J., Yao, B., Ma, L., Yang, Z., Li, J., & Liu, B. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.500 · Cited by 82
Self-citationChen, F., Wang, H., Zhu, J., Zhao, R., Xue, P., Zhang, Q., Nelson, M. B., Qu, W., Feng, B., & Pi, J. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.317 · Cited by 81
Sobhakumari, A., Love-Homan, L., Fletcher, E. V. M., Martin, S. M., Parsons, A. D., Spitz, D. R., Knudson, C. M., & Simons, A. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048175 · Cited by 80
Höll, M., Kozieł, R., Schäfer, G., Pircher, H., Pauck, A., Hermann, M., Klocker, H., Jansen‐Dürr, P., & Sampson, N. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22255 · Cited by 79
Ai, Y., Zhu, B., Ren, C., Kang, F., Li, J., Huang, Z., Lai, Y., Peng, S., Ding, K., Tian, J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01203 · Cited by 79
Naiki, T., Naiki‐Ito, A., Asamoto, M., Kawai, N., Tozawa, K., Etani, T., Sato, S., Suzuki, S., Shirai, T., Kohri, K., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu048 · Cited by 78
Narang, V. S., Pauletti, G. M., Gout, P. W., Buckley, D. J., & Buckley, A. R. (2007) · Chemotherapy · doi:10.1159/000100812 · Cited by 78
Ramkumar, K., Samanta, S., Kyani, A., Yang, S., Tamura, S., Ziemke, E. K., Stuckey, J. A., Li, S., Chinnaswamy, K., Otake, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms13084 · Cited by 78
Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer
Kim, E. H., Jang, H., Shin, D., Baek, S. H., & Roh, J.-L. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1284-8 · Cited by 77
CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
Li, Z., Chen, K., Jiang, P., Zhang, X., Li, X., & Li, Z. (2014) · Diagnostic Pathology · doi:10.1186/1746-1596-9-79 · Cited by 77
The Endoplasmic Reticulum Chaperone Calnexin Is a NADPH Oxidase NOX4 Interacting Protein
Prior, K.-K., Wittig, I., Leisegang, M. S., Groenendyk, J., Weißmann, N., Michalak, M., Jansen‐Dürr, P., Shah, A. M., & Brandes, R. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.710772 · Cited by 77
Membranes as Structural Antioxidants
Schmid‐Siegert, E., Stepushenko, O., Glauser, G., & Farmer, E. E. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.729921 · Cited by 77
Fiskus, W. C., Coothankandaswamy, V., Chen, J., Ma, H., Ha, K., Saenz, D. T., Krieger, S., Mill, C. P., Sun, B., Huang, P., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0126 · Cited by 77
Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B
El‐Senduny, F. F., Badria, F. A.-E., El‐Waseef, A. M., Chauhan, S. C., & Halaweish, F. T. (2015) · Tumor Biology · doi:10.1007/s13277-015-3773-8 · Cited by 76
Rocha, G. D. G., Simões, M., Lúcio, K. A., de Oliveira, R. C., Kaplan, M. A. C., & Gattass, C. R. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.07.020 · Cited by 76
Nrf2 overexpression is associated with P-glycoprotein upregulation in gastric cancer
Jeddi, F., Soozangar, N., Sadeghi, M. R., Somi, M. H., Shirmohamadi, M., Eftekhar-Sadat, A.-T., & Samadi, N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.129 · Cited by 75
Kausar, H., Munagala, R., Bansal, S. S., Aqil, F., Vadhanam, M. V., & Gupta, R. C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.008 · Cited by 75
Jardim, B. V., Moschetta, M. G., Leonel, C., Gelaleti, G. B., Regiani, V. R., Ferreira, L. C., Lopes, J. R., & Zuccari, D. A. P. D. C. (2013) · Oncology Reports · doi:10.3892/or.2013.2540 · Cited by 74
Akan, I., Akan, S., Akça, H., Savaş, B., & Özben, T. (2005) · Cancer Cell International · doi:10.1186/1475-2867-5-22 · Cited by 73
Zhao, Y., Chen, S., Jiao, J., Sun, K., & Zong, Z. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s87526 · Cited by 72
The see-saw of Keap1-Nrf2 pathway in cancer
Pandey, P., Singh, A. K., Singh, M., Tewari, M., Shukla, H. S., & Gambhir, I. S. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.02.006 · Cited by 71
Song, Y., Jang, J.-W., Shin, T., Bae, S. M., Kim, J., Kim, K. M., Myung, S., Choi, E. K., & Seo, H. R. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0511-7 · Cited by 71
Choi, B.-H., Ryoo, I.-G., Kang, H. C., & Kwak, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107158 · Cited by 70
Ge, C., Cao, B., Dong, F., Zhou, F., Zhang, J., Yang, N., Feng, S., Wang, G., & Aa, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03881-9 · Cited by 69
Turanov, A. A., Kehr, S., Marino, S. M., Yoo, M., Carlson, B. A., Hatfield, D. L., & Gladyshev, V. N. (2010) · Biochemical Journal · doi:10.1042/bj20091378 · Cited by 68
Regulation of anoikis resistance by NADPH oxidase 4 and epidermal growth factor receptor
Kim, H., Sung, J. Y., Park, E., Kho, S., Koo, K. H., Park, S.-Y., Goh, S., Jeon, Y. K., Oh, S., Park, B.-K., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2016.440 · Cited by 68
Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells
Starheim, K. K., Holien, T., Misund, K., Johansson, I., Baranowska, K. A., Sponaas, A.-M., Hella, H., Buene, G., Waage, A., Sundan, A., et al. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.56 · Cited by 66
Kim, E. H., Baek, S. H., Shin, D., Lee, J., & Roh, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5498908 · Cited by 66
Ali, D., Jönsson-Videsäter, K., Deneberg, S., Bengtzén, S., Nahi, H., Paul, C., & Lehmann, S. (2011) · European Journal of Haematology · doi:10.1111/j.1600-0609.2010.01557.x · Cited by 65
Expression of xCT as a predictor of disease recurrence in patients with colorectal cancer.
Sugano, K., Maeda, K., Ohtani, H., Nagahara, H., Shibutani, M., & Hirakawa, K. (2015) · PubMed · Cited by 65
Lin, M.-H., Lee, Y., Cheng, H.-L., Chen, H.-Y., Jhuang, F.-H., & Chueh, P. J. (2016) · Molecules · doi:10.3390/molecules21070849 · Cited by 65
Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1
Hang, W., Yin, Z.-X., Liu, G., Zeng, Q., Shen, X., Sun, Q., Li, D., Jian, Y., Zhang, Y.-H., Wang, Y., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0110-2 · Cited by 65
The chemopreventive agent phenethyl isothiocyanate sensitizes cells to Fas-mediated apoptosis
Pullar, J. M., Thomson, S. J., King, M. J., Turnbull, C. I., Midwinter, R. G., & Hampton, M. B. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh063 · Cited by 64
Taddia, L., D’Arca, D., Ferrari, S., Marraccini, C., Severi, L., Ponterini, G., Assaraf, Y. G., Marverti, G., & Costi, M. P. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.10.003 · Cited by 64
Self-citationMiyata, Y., Matsuo, T., Sagara, Y., Ohba, K., Ohyama, K., & Sakai, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102214 · Cited by 64
Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin
Wang, X., Govind, S., Sajankila, S. P., Mi, L., Roy, R., & Chung, F. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000560 · Cited by 63
Shitara, K., Doi, T., Nagano, O., Fukutani, M., Hasegawa, H., Nomura, S., Sato, A., Kuwata, T., Asai, K., Einaga, Y., et al. (2017) · Gastric Cancer · doi:10.1007/s10120-017-0720-y · Cited by 63
Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase
List, A. F., Kopecky, K. J., Willman, C. L., Head, D. R., Slovak, M. L., Douer, D., Dakhil, S. R., & Appelbaum, F. R. (2002) · Blood · doi:10.1182/blood.v100.5.1910.h81702001910_1910_1912 · Cited by 62
Chen, X., Bai, X., Hou, X., Gou, X., Wang, Y.-T., Zeng, H., Huang, M., & Jin, J. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430398 · Cited by 62
Liu, C., Hua, K., Li, K., Kao, H., Hong, R., Ko, J., Hsiao, M., Kuo, M., & Tan, C. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0567-t · Cited by 62
Deben, C., Deschoolmeester, V., Waele, J. D., Jacobs, J., den Bossche, J. V., Wouters, A., Peeters, M., Rolfo, C. D., Smits, E., Lardon, F., et al. (2018) · Cancers · doi:10.3390/cancers10040126 · Cited by 62
Chueh, P. J., Wu, L., Morré, D. M., & Morré, D. J. (2004) · PubMed · Cited by 61
Deben, C., Lardon, F., Wouters, A., de Beeck, K. O., den Bossche, J. V., Jacobs, J., Steen, N. V. D., Peeters, M., Rolfo, C. D., Deschoolmeester, V., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.017 · Cited by 61
[27] Glutathione reductase from bovine brain
Dringen, R., & Gutterer, J. M. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)48646-6 · Cited by 60
Holley, A. K., Xu, Y., Clair, D. K. S., & Clair, W. H. S. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05613.x · Cited by 60
Wang, Z., Liang, S., Lian, X., Liu, L., Zhao, S., Xuan, Q., Guo, L., Liu, H., Yang, Y., Dong, T., et al. (2015) · Scientific Reports · doi:10.1038/srep09301 · Cited by 60
Raninga, P. V., Trapani, G. D., Vučković, S., & Tonissen, K. F. (2016) · Cell Cycle · doi:10.1080/15384101.2015.1136038 · Cited by 59
Association of GSTP1 expression with resistance to docetaxel and paclitaxel in human breast cancers
Arai, T., Miyoshi, Y., Kim, S. J., Akazawa, K., Maruyama, N., Taguchi, T., Tamaki, Y., & Noguchi, S. (2007) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2007.07.008 · Cited by 58
Zhao, Q., Mao, A., Guo, R., Zhang, L., Yan, J., Sun, C., Tang, J., Ye, Y., Zhang, Y., & Zhang, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16622 · Cited by 58
Lorendeau, D., Dury, L., Genoux‐Bastide, E., Lecerf-Schmidt, F., Simões‐Pires, C. A., Carrupt, P., Terreux, R., Magnard, S., Pietro, A. D., Boumendjel, A., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.05.017 · Cited by 57
Cierlitza, M., Chauvistré, H., Bogeski, I., Zhang, X., Hauschild, A., Herlyn, M., Schadendorf, D., VOGT, T. M., & Roesch, A. (2014) · Experimental Dermatology · doi:10.1111/exd.12613 · Cited by 56
Roh, J., Kim, E. H., Jang, H.-J., & Shin, D. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.002 · Cited by 56
A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer
Coppola, S., Carnevale, I., Danen, E. H. J., Peters, G. J., Schmidt, T., Assaraf, Y. G., & Giovannetti, E. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.07.001 · Cited by 56
Self-citationNADPH Oxidases as Therapeutic Targets in Chronic Myelogenous Leukemia
Sánchez-Sánchez, B., Gutiérrez-Herrero, S., López-Ruano, G., Prieto-Bermejo, R., Romo-González, M., Llanillo, M., Pandiella, A., Guerrero, C., Miguel, J. F. S., Sanchez-Guijo, F. M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3044 · Cited by 55
Navarro, A., Bández, M. J., Gómez, C., Repetto, M. G., & BOVERIS, A. (2010) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-010-9309-4 · Cited by 55
Peroxisomes protect lymphoma cells from HDAC inhibitor-mediated apoptosis
Dahabieh, M. S., Ha, Z., Pietro, E. D., Nichol, J. N., Bolt, A. M., Gonçalves, C., Dupéré-Richer, D., Pettersson, F., Mann, K. K., Braverman, N., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.115 · Cited by 55
Hall, M. D., Marshall, T. S., Kwit, A. D. T., Jenkins, L. M. M., Dulcey, A. E., Madigan, J. P., Pluchino, K. M., Goldsborough, A. S., Brimacombe, K. R., Griffiths, G. L., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.581702 · Cited by 54
Filomeni, G., Turella, P., Dupuis, M. L., Forini, O., Ciriolo, M. R., Cianfriglia, M., Pezzola, S., Federici, G., & Caccuri, A. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0487 · Cited by 54
Zou, Z., Nie, P., Li, Y., Hou, B., Rui-li, Shi, X., Ma, Z., Han, B., & Luo, X. (2015) · Oncotarget · doi:10.18632/oncotarget.5628 · Cited by 54
Weston, L. A., Burke, B. A., & Putnam, A. R. (1987) · Journal of Chemical Ecology · doi:10.1007/bf01880089 · Cited by 53
Anderson, C., & Reynolds, C. P. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703605 · Cited by 53
Shiozaki, A., Iitaka, D., Ichikawa, D., Nakashima, S., Fujiwara, H., Okamoto, K. K., Kubota, T., Komatsu, S., Kosuga, T., Takeshita, H., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0847-5 · Cited by 52
Li, W., Nichols, K., Nathan, C. O., & Zhao, Y. (2013) · Cancer Biomarkers · doi:10.3233/cbm-130369 · Cited by 51
The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer
Geng, M., Wang, L., Chen, X., Cao, R., & Li, P. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-198 · Cited by 51
Liu, X., Zhang, S., Whitworth, R. J., Stuart, J. J., & Chen, M. (2015) · Scientific Reports · doi:10.1038/srep08092 · Cited by 50
Lin, S., Lei, K., Du, W., Yang, L., Shi, H., Gao, Y., Yin, P., Liang, X., & Liu, J. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.12.003 · Cited by 48
Cho, S. K., Pedram, A., Levin, E. R., & Kwon, Y. J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.003 · Cited by 47
Oliva, C. R., Markert, T., Ross, L. J., White, E. L., Rasmussen, L. A., Zhang, W., Everts, M., Moellering, D. R., Bailey, S. M., Suto, M. J., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.749978 · Cited by 47
Glutathione peroxidase 7 suppresses cancer cell growth and is hypermethylated in gastric cancer
Chen, Z., Hu, T., Zhu, S., Mukaisho, K., El-Rifai, W. M., & Peng, D. (2017) · Oncotarget · doi:10.18632/oncotarget.17527 · Cited by 47
Self-citationA novel agent exerts antitumor activity in breast cancer cells by targeting mitochondrial complex II
Wang, L., Zhang, X., Cui, G., Chan, J. Y., Li, C., Xu, C., Shan, L., Xu, C., Zhang, Q., Wang, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8410 · Cited by 46
Pasqua, A. J. D., Hong, C., Wu, M. Y., McCracken, E., Wang, X., Mi, L., & Chung, F. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100187f · Cited by 45
Su, W.-P., Lo, Y.-C., Yan, J., Liao, I., Tsai, P.-J., Wang, H., Yeh, H.-H., Lin, C., Chen, H. H. W., Lai, W., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs253 · Cited by 45
Zhang, G., Wang, W., Yao, C., Ren, J., Zhang, S., & Han, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.095 · Cited by 45
Wang, Q. (2011) · Oncology Reports · doi:10.3892/or.2011.1405 · Cited by 44
Yuan, Y., Yao, Y. F., Hu, S. N., Gao, J., & Zhang, L.-L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129843 · Cited by 43
An important role for peroxiredoxin II in survival of A549 lung cancer cells resistant to gefitinib
Kwon, T., Rho, J. K., Lee, J. C., Park, Y., Shin, H., Cho, S., Kang, Y., Kim, B.-Y., Yoon, D., & Yu, D. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.24 · Cited by 43
Kumar, A. P., Loo, S. Y., Shin, S. W., Tan, T. Z., Eng, C. B., Singh, R., Putti, T. C., Ong, C. W., Salto‐Tellez, M., Goh, B. C., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5295 · Cited by 43
Chen, P.-M., Cheng, Y., Wu, T., Chen, C., & Lee, H. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.12.001 · Cited by 42
Tan, Q., Li, J., Yin, H., Wang, L., Tang, W.-C., Zhao, F., Liu, X., & Zeng, H. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9235-7 · Cited by 42
Rocha, G. D. G., de Oliveira, R. C., Kaplan, M. A. C., & Gattass, C. R. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.054 · Cited by 42
Peroxiredoxin proteins protect MCF-7 breast cancer cells from doxorubicin-induced toxicity
McDonald, C., Muhlbauer, J., Perlmutter, G., Taparra, K., & Phelan, S. A. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2398 · Cited by 42
Caetano-Pinto, P., Jansen, J., Assaraf, Y. G., & Masereeuw, R. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.01.002 · Cited by 42
Self-citationXu, J., Zhang, S., Wang, R., Wu, X., Zeng, L., & Fu, Z. (2017) · Bioscience Reports · doi:10.1042/bsr20160447 · Cited by 42
Vara, D. S., Watt, J. M., Fortunato, T. M., Mellor, H., Burgess, M. O., Wicks, K., Mace, K. A., Reeksting, S. B., Lubben, A., Wheeler-Jones, C. P. D., et al. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6869 · Cited by 42
Ma, L., Fu, Q., Xu, B., Zhou, H., Gao, J., Shao, X., Xiong, J., Gu, Q., Wen, S., Li, F., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31207 · Cited by 42
GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma
Liu, T., Kan, X., Ma, C., Chen, L.-L., Cheng, T., Zou, Z., Li, Y., Cao, F., Zhang, W., Yao, J., et al. (2017) · Tumor Biology · doi:10.1177/1010428317700410 · Cited by 40
Prasai, P. K., Shrestha, B., Orr, A. W., & Pattillo, C. B. (2018) · Redox Biology · doi:10.1016/j.redox.2018.07.015 · Cited by 40
Tentori, L., Dorio, A. S., Mazzon, E., Muzi, A., SAU, A. C., Cuzzocrea, S., Vernole, P., Federici, G., Caccuri, A. M., & Graziani, G. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.12.008 · Cited by 39
Fu, T., Hou, Y., Chu, S., Liu, C., Huang, C., Chen, H., Hsiao, M., Lu, P., Wang, J., & Ger, L. (2011) · Head & Neck · doi:10.1002/hed.21653 · Cited by 39
Self-citationGan, X., Chen, B., Shen, Z., Liu, Y., Li, H., Xie, X., Xu, X.-Q., Li, H., Huang, Z., & Chen, J. (2014) · PubMed Central · Cited by 39
Adverse Events to Nontargeted and Targeted Chemotherapeutic Agents
Baldo, B. A., & Pagani, M. (2014) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2014.04.003 · Cited by 38
Samatiwat, P., Prawan, A., Senggunprai, L., Kukongviriyapan, U., & Kukongviriyapan, V. (2016) · Tumor Biology · doi:10.1007/s13277-016-5015-0 · Cited by 38
Drozd, E., Krzysztoń-Russjan, J., Marczewska, J., Drozd, J., Bubko, I., Bielak, M., Lubelska, K., Wiktorska, K., Chilmończyk, Z., Anuszewska, E., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.051 · Cited by 38
Qu, Y.-C., Cong, P., Lin, C.-J., Deng, Y., Li‐Ling, J., & Zhang, M. (2017) · Oncology Letters · doi:10.3892/ol.2017.6148 · Cited by 38
Pham, A., Blower, P. E., Alvarado, O., Ravula, R., Gout, P. W., & Huang, Y. S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162248 · Cited by 37
Hou, X., Bai, X., Gou, X., Zeng, H., Chen, X., Zhuang, W., Chen, X., Zhao, Z., Huang, M., & Jin, J. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.2183 · Cited by 37
Yamamoto, T., Nakano, H., Shiomi, K., Wanibuchi, K., Masui, H., Takahashi, T., Urano, Y., & Kamata, T. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00804 · Cited by 37
Myers, C. R. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.008 · Cited by 36
Li, Q., Zhan, M., Chen, W., Zhao, B., Yang, K., Yang, J., Yi, J., Huang, Q., Mohan, M., Hou, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7171 · Cited by 36
Self-citationAn, B. C., Jung, N.-K., Park, C. Y., Oh, I., Choi, Y. D., Park, J., & Lee, S.-W. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0164 · Cited by 36
Zheng, X., Zhang, Y., Zhang, L. J., Xu, W., Ma, W., Sun, R., & Zeng, H. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.040 · Cited by 35
Flavonoid dimers are highly potent killers of multidrug resistant cancer cells overexpressing MRP1
Dury, L., Nasr, R., Lorendeau, D., Comsa, E., Wong, I. L. K., Zhu, X., Chan, K., Chan, T. H., Chow, L. M. C., Falson, P., et al. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.10.013 · Cited by 35
CRISPR-Cas9 Mediated NOX4 Knockout Inhibits Cell Proliferation and Invasion in HeLa Cells
Jafari, N., Kim, H.-J., Park, R., Li, L., Jang, M., Morris, A. J., Park, J., & Huang, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170327 · Cited by 35
Li, L., & Yu, A.-Q. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-1916-3 · Cited by 34
Hernández‐Breijo, B., Monserrat, J., Ramirez-Rubio, S., Cuevas, E. P., Vara‐Ciruelos, D., Díaz‐Laviada, I., Fernández-Moreno, M. D., Román, I. D., Gisbert, J. P., & Guijarro, L. G. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i34.3899 · Cited by 34
Wang, L., Fu, J., Wang, J., Jin, C., Ren, X., Tan, Q., Li, J., Yin, H., Xiong, K., Wang, T., et al. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32834618bc · Cited by 34
Self-citationHe, T., Banach-Latapy, A., Vernis, L., Dardalhon, M., Chanet, R., & Huang, M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs389 · Cited by 34
Biomarkers of oxidative stress in patients with wet age related macular degeneration
Zafrilla, P., Losada, M., Pérez, A., Caravaca, G., & Mulero, J. (2012) · The journal of nutrition health & aging · doi:10.1007/s12603-012-0095-z · Cited by 33
Wang, C., Wu, H. T., Cheng, H. M., Yen, T.-J., Lu, I.-H., Chang, H. C., Jao, S., Shing, T. K. M., & Li, W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201131n · Cited by 33
Levine, A. S., Sun, L., Tan, R., Gao, Y. D., Yang, L., Chen, H., Teng, Y., & Lan, L. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9184-6 · Cited by 33
Wang, P. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i20.6271 · Cited by 31
Jia, Y., Zhang, C., Zhou, L., Shi, Y., Tong, Z., & Xu, H. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s88661 · Cited by 31
Design, Synthesis, and Preliminary Cardioprotective Effect Evaluation of Danshensu Derivatives
Cui, Q., Chen, Y., Zhang, M., Shan, L., Sun, Y., Yu, P., Zhang, G., Wang, D., Zhao, Z., Xu, Q., et al. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12312 · Cited by 31
Self-citationYeung, B. H. Y., Wong, K. Y., Lin, M. C., Wong, C. K. C., Mashima, T., TSURUO, T., & Wong, A. S. T. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604477 · Cited by 31
Zafar, A., Singh, S., Satija, Y. K., Saluja, D., & Naseem, I. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.10.007 · Cited by 31
Huang, Z., Liu, Y., Huang, Z., Li, H., Gan, X., & Shen, Z. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3341 · Cited by 30
Schulz, R., Emmrich, T., Lemmerhirt, H., Leffler, U., Sydow, K., Hirt, C., Kiefer, T., Link, A., & Bednarski, P. J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.08.091 · Cited by 29
Hai-ya, H., Niu, J., & Lü, Y. (2011) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.4551 · Cited by 29
Leonel, C., Gelaleti, G. B., Jardim, B. V., Moschetta, M. G., Regiani, V. R., de Oliveira, J. G., & Zuccari, D. A. P. D. C. (2014) · BMC Veterinary Research · doi:10.1186/1746-6148-10-49 · Cited by 29
xCT expression modulates cisplatin resistance in Tca8113 tongue carcinoma cells
Zhang, P., Wang, W., WEI, Z., Li, X., YANG, X., & Du, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.4571 · Cited by 29
Li, C., Wu, H.-T., Wang, S., & Zhu, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5913 · Cited by 29
Liu, W., Zhao, C., Wang, P., Wang, S., Lin, H., & Qiu, L. (2017) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2017.12.009 · Cited by 29
Lin, L.-C., Chen, C., Ho, C.-T., Liu, J., Liu, T., & Chern, C. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.02.015 · Cited by 29
Inhibition of glutathione synthesis reverses Krüppel-like factor 4-mediated cisplatin resistance
Jia, Y., Zhang, W., Liu, H., Peng, L., Yang, Z., & Lou, J. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1708-7 · Cited by 28
Selective killing of K-ras–transformed pancreatic cancer cells by targeting NAD(P)H oxidase
Wang, P., Sun, Y.-C., Lu, W.-H., Huang, P., & Hu, Y. (2015) · 癌症:英文版 · doi:10.1186/s40880-015-0012-z · Cited by 28
Lewis-Wambi, J. S., Swaby, R. F., Kim, H., & Jordan, V. C. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.12.016 · Cited by 27
Disturbance of redox status enhances radiosensitivity of hepatocellular carcinoma.
Sun, C., Wang, Z., Liu, X., Yang, L., Wang, Y., Liu, Y., Mao, A., Liu, Y.-Y., Zhou, X. H., Di, C., et al. (2015) · Europe PMC (PubMed Central) · Cited by 26
Hong, S., Park, N.-S., Noh, M. H., Shim, J. A., Ahn, B., Kim, Y. S., Kim, D., Lee, H.-K., & Hur, D. Y. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.02.009 · Cited by 26
Wei, X., Mo, X., An, F., Ji, X., & Lü, Y. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.04.001 · Cited by 26
Collateral sensitivity: ABCG2-overexpressing cells are more vulnerable to oxidative stress
Krzyżanowski, D., Bartosz, G., & Grzelak, A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.020 · Cited by 25
Correlation Between Nuclear Factor E2-Related Factor 2 Expression and Gastric Cancer Progression
Zheng, H., Nong, Z., & Lu, G. (2015) · Medical Science Monitor · doi:10.12659/msm.894467 · Cited by 25
Cited by
Biomedicine Meets Fenton Chemistry
Tang, Z., Zhao, P., Wang, H., Liu, Y., & Bu, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00977 · Cited by 745
CRISPR/Cas9 therapeutics: progress and prospects
Li, T., Yang, Y., Qi, H., Cui, W., Zhang, L., Fu, X., He, X., Liu, M., Li, P.-F., & Yu, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01309-7 · Cited by 719
The interaction between ferroptosis and lipid metabolism in cancer
Li, D., & Li, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00216-5 · Cited by 703
Erin, N., Grahovac, J., Brozovic, A., & Efferth, T. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100715 · Cited by 527
NAD+ metabolism, stemness, the immune response, and cancer
Navas, L. E., & Carnero, A. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00354-w · Cited by 517
Metadata
- Authors
- Cui, Q., Wang, J.-Q., Assaraf, Y. G., Ren, L., Gupta, P., Wei, L., Ashby, C. R., Yang, D.-H., & Chen, Z.-S.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 41
- Pages
- 1-25
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2901265038
- Cited by
- 661
- References
- 435
- FWCI
- 16.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.